AnandRathi

Glenmark Pharmaceuticals Ltd Fundamental Analysis

Last Updated Date: 07 Oct 2026
₹2,295.15
+6.20 (+0.27%)

Glenmark Pharmaceuticals Ltd (Glenmark Pharma.) fundamental analysis breaks down the key financial metrics of the mid-cap Pharmaceuticals company, which carries a market capitalisation of ₹64,600 crore.

Glenmark Pharmaceuticals Ltd Overview

Market cap₹64,600 Crs
Volume9,375
Prev. Close₹2,288.95
Year range₹1,794.00 - ₹2,536.85
ISININE935A01035

Glenmark Pharmaceuticals Ltd Fundamentals

ROCE(TTM)6.29%
P/E Ratio (TTM)315.72
P/B Ratio2.67
Debt to Equity0.00
ROE6.63%
EPS (TTM)51.73
Dividend Yield0.22%
Book Value855.71
Profit Margin18.03%
Operating Margin8.51%

Glenmark Pharmaceuticals Ltd Historical Performance

1 Month Return-7.03%
6 Month Return8.77%
3 Year Return188.39%
3 Month Return0.81%
1 Year Return16.12%
5 Year Return334.50%

Glenmark Pharmaceuticals Ltd Share Price History

High:0.00
Low:0.00
No History Available

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research